Patient Stories

"Painful sex does not have to be my story"
-Susan S., IMVEXXY Patient

Explore more patient stories below.

PATIENT STORIES

"Painful sex does not have to be my story"
-Susan S., IMVEXXY Patient

Explore more patient stories below.

Women Are Finally Speaking Up About Menopause and the Stigma of Vulvar and Vaginal Atrophy

Too many menopausal women suffer in silence while managing symptoms like vaginal discomfort and pain associated with sex. It’s important to remember you aren’t alone. Meet Jennifer, Carla and Susan. Here they share their personal experiences with vulvar and vaginal atrophy, including how they found relief from painful sex with IMVEXXY and why they wish they’d spoken up sooner.

X

Meet Jennifer

For me, the symptoms of vulvar and vaginal atrophy and painful sex during menopause extended beyond physical pain—there was also a mental component. I thought, is this going to be my life moving forward? When I finally talked to my healthcare provider and learned about my options, I wished I hadn’t waited so long!
Meet Carla

It puts a strain on an important part of your relationship. I had heard about pain and dryness during sex due to menopause, but I wasn’t anticipating this kind of pain. For a while, I just dealt with it, thinking maybe this will pass. When it didn’t, I knew it was time to speak up.

Meet Susan

I felt so alone—so isolated. After a year of pain, I went to my gynecologist and cried. I was shocked when she told me the pain and dryness were due to menopause and could be treated. I didn’t expect that to be part of the journey. I thought it was just me.

HEAR MORE ABOUT MENOPAUSE FROM THESE WOMEN
(AND HOW THEY FOUND RELiEF WiTH IMVEXXY)

While painful sex due to menopause can take a physical toll, the emotional impact can often be just as difficult to bear. These women have each been there, and by sharing how they found the courage to take control of their health, they hope to empower you to do the same.

Talking About It

When intimacy after menopause becomes associated with pain, it can be an isolating experience for both partners. Talking openly about what’s wrong is the first step toward finding lasting relief.

Words Of Encouragement

Don’t be afraid to prioritize your sexual health! You don’t have to go through this alone.

OK, SO HOW DO I
GET IMVEXXY?

You don't have to wait until your annual check-up. Speak to a healthcare provider or get an
IMVEXXY prescription online. Have any questions? Call us at 855-IMVEXXY.

GET IMVEXXY

Important Risk Information

WARNING: ENDOMETRIAL CANCER, CARDIOVASCULAR DISORDERS, PROBABLE DEMENTIA and BREAST CANCER

See full prescribing information for complete boxed warning.


Estrogen-Alone Therapy

  • There is an increased risk of endometrial cancer in a woman with a uterus who uses unopposed estrogens
  • The Women’s Health Initiative (WHI) estrogen-alone substudy reported increased risks of stroke and deep vein thrombosis (DVT)
  • The WHI Memory Study (WHIMS) estrogen-alone ancillary study of WHI reported an increased risk of probable dementia in postmenopausal women 65 years of age and older
  • Do not use estrogen-alone therapy for the prevention of cardiovascular disease or dementia

Estrogen Plus Progestin Therapy

  • The WHI estrogen plus progestin substudy reported increased risks of stroke, DVT, pulmonary embolism (PE) and myocardial infarction (MI)
  • The WHI estrogen plus progestin substudy reported increased risks of invasive breast cancer
  • The WHIMS estrogen plus progestin ancillary study of WHI reported an increased risk of probable dementia in postmenopausal women 65 years of age and older
  • Do not use estrogen plus progestogen therapy for the prevention of cardiovascular disease or dementia

The WHI estrogen-alone and estrogen plus progestin substudies evaluated only daily oral conjugated estrogens (CE) [0.625 mg] and medroxyprogesterone acetate (MPA) [2.5 mg]. Therefore, the relevance of the WHI findings regarding adverse cardiovascular events, dementia, and breast cancer to lower CE and MPA doses, other routes of administration, or other estrogen-alone or estrogen plus progestogen products is not known, and cannot be definitively excluded or determined.

MOST IMPORTANT INFORMATION YOU SHOULD KNOW ABOUT IMVEXXY(an estrogen hormone)

  • Using estrogen-alone may increase your chance of getting cancer of the uterus (womb).
  • Report any unusual vaginal bleeding right away while you are using IMVEXXY. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb). Your healthcare provider should check any unusual vaginal bleeding to find out the cause.
  • Do not use estrogen-alone to prevent heart disease, heart attacks, strokes, or dementia (decline of brain function).
  • Using estrogen-alone may increase your chances of getting strokes or blood clots.
  • Using estrogen-alone may increase your chance of getting dementia, based on a study of women 65 years of age and older.
  • Do not use estrogens with progestogens to prevent heart disease, heart attacks, strokes or dementia.
  • Using estrogens with progestogens may increase your chance of getting dementia, based on a study of women 65 years of age and older.
  • Only one estrogen-alone product and dose have been shown to increase your chances of getting strokes, blood clots, and dementia. Only one estrogen with progestogen product and dose have been shown to increase your chances of getting heart attacks, strokes, breast cancer, blood clots, and dementia. Because other products and doses have not been studied in the same way, it is not known how the use of IMVEXXY will affect your chances of having these conditions.
  • Talk to your healthcare provider regularly about whether you still need treatment with IMVEXXY.

Do not use if you

  • have unusual vaginal bleeding.
  • have been diagnosed with a bleeding disorder.
  • currently have or have had certain cancers.
  • currently have or have had blood clots.
  • had a stroke or heart attack.
  • currently have or have had liver problems.
  • are allergic to IMVEXXY or any of its ingredients.

Warnings

Tell your healthcare provider about all of your medical conditions, including if you:

  • have any unusual vaginal bleeding.
  • have any other medical conditions that may become worse while you are using IMVEXXY.
  • have asthma (wheezing), epilepsy (seizures), diabetes, migraine, endometriosis, lupus, angioedema (swelling of face and tongue), problems with your heart, liver, thyroid, kidneys, or have high calcium levels in your blood.
  • are going to have surgery or will be on bed rest. You may need to stop using IMVEXXY.
  • are pregnant or think you may be pregnant. Imvexxy is not for pregnant women.
  • are breast feeding.

Tell your healthcare provider about all the medicines you take.

IMVEXXY may affect the way other medicines work, and other medicines may affect how IMVEXXY works.

When using IMVEXXY you may have

  • headache
  • breast tenderness or pain
  • nausea and vomiting

USE

IMVEXXY (estradiol vaginal inserts) is a prescription medicine that contains an estrogen hormone in a vaginal insert. It is used after menopause to treat moderate to severe painful intercourse, a symptom of changes in and around your vagina, due to menopause.



The risk information provided here is not complete. To learn more, talk about IMVEXXY with your healthcare provider or pharmacist. The FDA-approved product labeling can be found here.



You are encouraged to report negative side effects of prescription drugs to the FDA. Visit MedWatch, or call 1-800-FDA-1088.

Please Wait